发明名称 |
CHROMOSOMAL MODIFICATION INVOLVING THE INDUCTION OF DOUBLE-STRANDED DNA CLEAVAGE AND HOMOLOGOUS RECOMBINATION AT THE CLEAVAGE SITE |
摘要 |
Methods of modifying, repairing, attenuating and inactivating a gene or other chromosomal DNA in a cell are disclosed. Also disclosed are methods of treating or prophylaxis of genetic disease in an individual in need thereof. Further disclosed are chimeric restriction endonucleases. |
申请公布号 |
US2015259655(A1) |
申请公布日期 |
2015.09.17 |
申请号 |
US201414550463 |
申请日期 |
2014.11.21 |
申请人 |
Children's Medical Center Corporation ;Institut Pasteur |
发明人 |
Choulika Andre;Mulligan Richard C. |
分类号 |
C12N9/22;C12N15/90 |
主分类号 |
C12N9/22 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for attenuating or inactivating an endogenous gene of interest in a cell comprising: inducing in the cell double stranded cleavage of chromosomal DNA at a genomic site of interest in the specific sequence to be modified, wherein the inducing comprises contacting the genomic site of interest with a chimeric restriction endonuclease, said chimeric restriction endonuclease comprising a DNA binding sequence and a DNA cleavage domain, and said restriction endonuclease recognizing a DNA sequence of at least 12 bp, wherein said restriction endonuclease is introduced as a protein or is encoded by a nucleic acid vector that is expressed, thereby inducing a cellular repair mechanism which leads to highly efficient recombinational events at said genomic site of interest, thereby modifying the specific sequence in the chromosomal DNA of the cell in a way of attenuating or inactivating an endogenous gene of interest in said cell. |
地址 |
Boston MA US |